Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
Status: | Recruiting |
---|---|
Conditions: | Psychiatric, Psychiatric, Bipolar Disorder |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 15 - 24 |
Updated: | 7/13/2018 |
Start Date: | September 2016 |
End Date: | January 2020 |
Contact: | Rachael Lyons, BS |
Email: | rmlyons@mgh.harvard.edu |
Phone: | 617-724-5226 |
A Randomized Controlled Trial of Quetiapine for the Treatment of Youth With Co-occurring Substance Use Disorders and Severe Mood Dysregulation
The purpose of this study is to determine whether quetiapine is effective in the treatment of
youth with co-occurring substance use disorders and severe mood dysregulation.
youth with co-occurring substance use disorders and severe mood dysregulation.
Inclusion Criteria:
- Male or female age 15 to 24
- Meet DSM-5 criteria for a substance use disorder
- Substance use ≥ 14 days of past 28 days (i.e. use ≥ 50% of days in the past 28 days)
- If subject in restricted setting/care (e.g. detox or residential treatment) for ≤ 2
weeks, then use ≥ 50% of days while outside of restricted setting (e.g. 7 days of
substance use out of 14 days in unrestricted setting)
- Subjects need to have been in an unrestricted setting for at least 2 weeks prior to
screening
- Meets DSM-5 criteria for bipolar disorder or disruptive mood dysregulation disorder or
DSM IV criteria for mood disorder NOS
- Symptoms of SMD: Youth Self Report (YSR) or Adult Self Report (ASR) AAA ≥180
- Stable to be treated in outpatient level of care
Exclusion Criteria:
- Current methamphetamine use disorder
- Current unstable opioid use disorder (i.e. < 3 months on medication assisted treatment
for an opioid use disorder)
- Pregnant or breastfeeding
- Placement in a restricted setting (e.g. detox or residential treatment) for ≥ 2 weeks
out of past 28 days prior to screening visit, or placement in a restricted setting at
anytime during study participation
- Unwilling or unable to use effective birth control
- Unwilling or unable to sign release of information for the treatment program providing
behavioral treatment
- For participants >17 years—unable or unwilling to identify emergency contact
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-5226
Click here to add this to my saved trials